Solid Biosciences Q1 2026 Earnings WiderthanExpected Loss as Biotech Advances Pipeline ATKR Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Execution JAGX Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges Gloo Holdings Inc GLOO Q4 2025 Earnings Net Loss of 078 per Share Stock Declines 26 Eikon Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline CLNN Q1 2026 Earnings Significant EPS Beat Despite PreRevenue Status and Stock Decline